
The penalty was imposed due to inconsistencies in service tax returns, the company said in the filing.
Zensar Tech is part of the $4.8-billion RPG Group conglomerate, with a total services revenue of $591.3 million as on March 2024.
The US is its largest market, accounting for 67.2% of the revenue share. The company said the penalty will have no material impact on its financials, operation or other activities.
In July, last year, Zensar Technologies had acquired a 100% membership interest in US-based BridgeView Life Sciences, through its wholly owned subsidiary Zensar Technologies Inc, for a total consideration of $25 million.